Regeneron to Add 2 New Bioreactors in NY Plant Expansion
Regeneron will add two new 10,000-litre bioreactors at its East Greenbush facility as part of an $80m expansion.
Archives for August 13, 2013
Flexible Tech Could Allow Rapid, Cheap Production of a Variety of Vaccines
New flexible vaccine technology could pave the way for pneumococcal, TB and staphylococcus aureus vaccines that are cheaper to produce and more effective.
Manufacturing Concerns Halt US Approval for Novo Nordisk's Factor XIII
Novo Nordisk says it has received a complete response letter for its recombinant factor XIII drug citing manufacturing concerns at a Danish facility.
Uptake in Single-Use is Changing Facility Design, Experts Say
Adapting stainless steel facilities to incorporate increased use of disposable technology can help reduce costs and improve quality compliance, say TFS and Lonza.
PharmAthene to Merge with Theraclone to Continue Developing mAbs, Vaccines
PharmAthene and Theraclone Sciences announced plans to merge and continue the joint development of monoclonal antibodies (mAbs) and vaccines on the verge of progressing to Phase II and III trials.